Welcome readers,
What will the UK’s investable property market look like in 2040? According to CBRE IM, the balance is set to tilt decisively: residential becomes the dominant theme, while tech assets — life sciences and data centres — post the strongest structural growth as offices and retail lose weight in the universe.
Beyond the feature, we cover 20 European deals capturing the full spectrum of activity: new labs, HQ consolidations, science-park acquisitions, specialist logistics and clinical research infrastructure.
🔒 Paying subscribers get 20 deals • Everyone else can explore 3 of them → Get full access by subscribing here.
— Stephen Ryan (connect with me on LinkedIn)
🔍 Do you need deeper insights into life sciences real estate?
In addition to our regular updates, we offer bespoke research and strategic analysis for investors and developers in the life sciences sector. Whether you’re evaluating an acquisition, tracking market trends, or need a custom report, our team can help you make informed decisions.
Get in touch to discuss how we can support your next project.
Featured article of the week
UK Real Estate in 2040
UK real estate by 2040 will be dominated by residential, with tech sectors (data centres, life sciences) growing as offices and retail decline, predicts CBRE IM.
Deals
FRANCE PARIS
Sanofi will relocate its French headquarters to La Défense business district, with completion expected in the second half of 2027. The building will occupy approximately 35,000 sq m across seven storeys, housing 2,700 employees with office space, restaurants and an auditorium. While comprising corporate office space rather than technical facilities, the headquarters consolidation represents a significant occupier signal for the Paris life sciences cluster. The project is being developed by WO2 on behalf of the Icawood investment fund, with structural work undertaken by French companies including GCC, Goyer and architectural firm Ateliers 2/3/4/.
GERMANY BAD GRÖNENBACH
Seybandgruppe has developed and fully let a 13,200 sq m logistics centre on a 28,000 sq m site at the A7 motorway between Kempten and Memmingen. The property has been let on long-term leases to two tenants: a Swiss freight forwarder serving the food sector and a logistics company specialising in clinic and pharma operations. Seybandgruppe acquired the site from Austrian company Adapa a year ago and relocated the previous occupier to enable the development. The building features 12 loading bays and 4 gates, with 24/7 operational capacity.
Would you like instant access to more deals like these? Our data tool lets you filter, sort and search European life sciences transactions spanning 24 countries—whether you're tracking a single city or spotting market patterns others miss.
GERMANY BERLIN
Development of iQ space Berlin-Mitte has moved into the main construction phase following appointment of general contractor WOLFF & MÜLLER and handover of the site. The circa 20,000 sq m, ten-storey building will provide laboratory, research and GMP pilot-production space for gene and cell therapies, alongside incubator and collaboration areas. The integrated facility forms part of the Bayer Open Innovation Campus at Berlin-Nordhafen, bringing together academic research, clinical practice and industry partners.
👇 As a free member, you get access to three deals for free.
Upgrade now to access the full list.
